Blackstone Life Sciences, a private investment company, is investing in Moderna, a drug firm known for its COVID-19 vaccines. This move is seen as beneficial for both companies, with Blackstone curing two ailments by making a big bet on Moderna.
Breakingviews - Europe’s IPO window opens slowly for buyout barons: podcast https://t.co/yqdhu0FfG3 https://t.co/yqdhu0FfG3
A strong start for Europe’s IPOs in 2024, driven by a handful of high-profile newcomers to the market, bodes well for a rebound in listings in the region for the rest of the year https://t.co/Q11DpkRwfR
From Breakingviews - Breakingviews - Europe’s IPO window opens slowly for buyout barons: podcast https://t.co/BTQGYnlgvz https://t.co/BTQGYnlgvz
Blackstone Life Sciences, a private investment company, is making a big bet on its Cambridge neighbor Moderna, the drug firm that has made multiple versions of a vaccine to fend off COVID-19. https://t.co/8HVPkHTLW0
From Breakingviews - Breakingviews - Blackstone cures two ailments in one Moderna shot https://t.co/WQS9uf9LpE https://t.co/WQS9uf9LpE